Prostate Cancer Screening Could Prevent 1,500 Deaths per Year in the UK

Strategic Insights -

Research conducted in one of the largest European trials found that prostate cancer screening can reduce mortality rates by 13%, with the potential to save around 1,500 lives annually in the UK. The study suggests that a targeted approach to screening is necessary, focusing on those at the greatest risk, such as black men and individuals with a family history of the disease. The findings are comparable to the effectiveness of breast and bowel cancer screening programs, according to commentators. The UK National Screening Committee is considering whether to recommend the introduction of prostate cancer screening, with The Telegraph campaigning for targeted screening to identify those most at risk.

Key Takeaways:

  • The European trial, involving 162,000 men, found that screening prevents one prostate cancer death for every 12 men diagnosed and every 456 men invited for screening.
  • The study found that screening has a "more favourable harm-to-benefit profile than previously estimated," but harms linked to screening, such as unnecessary tests and treatment, remain a concern.
  • Those offered screening had a 13% lower mortality rate, which could translate to between 800 and 1,500 fewer deaths annually in the UK.
  • The PSA test, a blood test commonly used for prostate cancer screening, has seen advances in backup diagnostics to confirm diagnoses, reducing the need for unnecessary procedures.
  • The UK National Screening Committee has previously rejected calls for screening due to the PSA test's unreliability, but recent advances in diagnostics have made the test more effective.
  • The study suggests a targeted approach to screening, focusing on subgroups most likely to benefit from early detection, while reducing unnecessary interventions.
  • Researchers recommend a "targeted strategy for prostate cancer screening" to maximize benefits and minimize harms.

Statistics:

  • The European trial involved 162,000 men over a 23-year period.
  • 72,000 men participated in the screening program.
  • One prostate cancer death is prevented for every 12 men diagnosed and every 456 men invited for screening.
  • The 13% lower mortality rate among those offered screening could translate to 800-1,500 fewer deaths annually in the UK.

Sources:

  • The Telegraph
  • New England Journal of Medicine (study referenced in the article)
  • UK National Screening Committee
  • The Telegraph's campaign for targeted prostate cancer screening